Neutropenic Sepsis in Patients With Non-Small Cell Lung Cancer Treated With Single-Agent Docetaxel and Associated Resource Use in the UK
Clinical trial NCT02658747 · COMPLETED
Trial details
- NCT number
- NCT02658747
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2016-05-25
- Primary completion
- 2016-07-25
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.